Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia

Hypertension

Volumn 60, Issue 2, 2012, Pages 451-458

  Rana, Sarosh ^a,b   Hacker, Michele R ^a,b   Modest, Anna Merport ^a   Salahuddin, Saira ^a,b   Lim, Kee Hak ^a   Verlohren, Stefan ^c   Perschel, Frank H ^c   Karumanchi, S Ananth ^a,b,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

adverse outcomes; angiogenic factors; preeclampsia; twin pregnancy

Indexed keywords

PLACENTAL GROWTH FACTOR; PROANGIOGENIC PLACENTAL GROWTH FACTOR; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ARTICLE; BRAIN HEMORRHAGE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMOLYSIS; HUMAN; HYPERTRANSAMINASEMIA; LOW PLATELET SYNDROME; LUNG EDEMA; MAJOR CLINICAL STUDY; NEWBORN DEATH; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEINURIA; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE DISORDER; TWIN PREGNANCY;

ACUTE KIDNEY INJURY; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FETAL DEATH; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, THIRD; PREGNANCY, TWIN; PROSPECTIVE STUDIES; PULMONARY EDEMA; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84864283759     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.195065     Document Type: Article

References (28)

1. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;99:159-167.
2. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36:56-59.
3. Ngoc NTN, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, Zavaleta N, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ. 2006; 84:699-705. (Pubitemid 44482395)
4. Friedman SA, Schiff E, Kao L, Sibai BM., Sibai BM. Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol.172: 1785-1788; discussion 1788-1792.
5. Santema JG, Koppelaar I, Wallenburg HC. Hypertensive disorders in twin pregnancy. Eur J Obstet Gynecol Reprod Biol. 1995;58:9-13.
6. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:938-942.
7. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-1672. (Pubitemid 27446230)
8. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: The "chicken-And-egg" question. Endocrinology. 2004;145:4835-4837. (Pubitemid 39551099)
9. Geipel A, Berg C, Germer U, Katalinic A, Krapp M, Smrcek J, et al. Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: Prediction of pre-eclampsia, fetal growth restriction and birth weight discordance. Ultrasound Obstet Gynecol. 2002;20: 541-545. (Pubitemid 36002611)
10. Geipel A, Hennemann F, Fimmers R, Willruth A, Lato K, Gembruch U, et al. Reference ranges for Doppler assessment of uterine artery resistance and pulsatility indices in dichorionic twin pregnancies. Ultrasound Obstet Gynecol. 2011;37:663-667.
11. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?. Am J Obstet Gynecol. 2008;198:428.e421-428.e426.
12. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683. (Pubitemid 38364626)
13. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005;17:3-18. (Pubitemid 40515938)
14. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009;22: 1021-1038.
15. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658. (Pubitemid 36278583)
16. Maynard SE, Moore Simas TA, Solitro MJ, Rajan A, Crawford S, Soderland P, et al. Circulating angiogenic factors in singleton vs multiplegestation pregnancies. Am J Obstet Gynecol. 2008;198:200.e201-200.e207.
17. Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2006;195:495-503. (Pubitemid 44142383)
18. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, et al. Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model. Lancet. 2011;377:219-227.
19. Klein K, Mailath-Pokorny M, Elhenicky M, Schmid M, Zeisler H, Worda C. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol. 2011;205:549.e541- 549.e547.
20. Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, et al. Maternal plasma concentrations of angiogenic/anti-Angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011;24:1187-1207.
21. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911-919.
22. E. Schneider AGaRHea. Technical performance of the first fully automated assays for soluble fms-like tyrosine kinase 1 and human placental growth factor. Z Geburtshilfe Neonatol. 2009;213:69.
23. Hauth JC, Clifton RG, Roberts JM, Spong CY, Myatt L, Leveno KJ, et al. Vitamin C and E supplementation to prevent spontaneous preterm birth: A randomized controlled trial. Obstet Gynecol. 2010; 116:653-658.
24. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010;202: 161.e1-161.e11.
25. Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, et al. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem. 2010;43:768-770.
26. Sunderji S, Gaziano E, Wothe D, Rogers LC, Sibai B, Karumanchi SA, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: A prospective clinical study. Am J Obstet Gynecol. 2010;202:40.e41-40.e47.
27. Wolf M, Shah A, Lam C, Martinez A, Smirnakis KV, et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol. 2005;193:16-22. (Pubitemid 40991821)
28. Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, et al. Maternal angiogenic profile in pregnancies that remain normotensive. Eur J Obstet Gynecol Reprod Biol. 2011;158:189-193.